Skip to main content

Advertisement

Table 3 Values from VAS and TTO exercises in the UK general public (n = 100)

From: A health state utility valuation study to assess the impact of treatment mode of administration in Gaucher disease

Health states VAS value(N = 100) TTO value(N = 100)
Controlled disease
 Mean (SD) 71.4 (17.9) 0.89 (0.11)
 Min - Max 10.0–98.0 0.45–1.00
Intravenous treatment
 Mean (SD) 50.0 (17.8) 0.73 (0.20)
 Min - Max 0.0–90.0 0.05–1.00
Oral treatment
 Mean (SD) 71.0 (17.1) 0.85 (0.15)
 Min - Max 10.0–96.0 0.25–1.00
Oral treatment, Alternative 1
 Mean (SD) 66.53 (17.49) 0.82 (0.23)
 Min - Max 20.0–97.0 −0.85-1.00
Oral treatment, Alternative 2
 Mean (SD) 59.1 (19.4) 0.78 (0.18)
 Min - Max 10.0–94.0 0.15–1.00
  1. SD, Standard deviation
  2. Oral treatment, alternative 1: reduced frequency of intake and side effects
  3. Oral treatment, alternative 2: higher frequency of intake and more frequent occurrence of side effects